Schultz et al., 2022 - Google Patents
Spectral fundus autofluorescence peak emission wavelength in ageing and AMDSchultz et al., 2022
View PDF- Document ID
- 11913032126035219067
- Author
- Schultz R
- Schwanengel L
- Klemm M
- Meller D
- Hammer M
- Publication year
- Publication venue
- Acta Ophthalmologica
External Links
Snippet
Purpose To investigate the spectral characteristics of fundus autofluorescence (FAF) in AMD patients and controls. Methods Fundus autofluorescence spectral characteristics was described by the peak emission wavelength (PEW) of the spectra. Peak emission …
- 230000003595 spectral 0 title abstract description 22
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/102—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sauer et al. | Fluorescence lifetime imaging ophthalmoscopy (FLIO) of macular pigment | |
| Sauer et al. | Impact of macular pigment on fundus autofluorescence lifetimes | |
| Sauer et al. | Fluorescence lifetime imaging ophthalmoscopy: a novel way to assess macular telangiectasia type 2 | |
| Yung et al. | Clinical applications of fundus autofluorescence in retinal disease | |
| Jentsch et al. | Retinal fluorescence lifetime imaging ophthalmoscopy measures depend on the severity of Alzheimer's disease | |
| Sauer et al. | Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy | |
| Dysli et al. | Fluorescence lifetime imaging in Stargardt disease: potential marker for disease progression | |
| Cideciyan et al. | ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina | |
| Sauer et al. | Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond | |
| Framme et al. | Fundus autofluorescence in acute and chronic‐recurrent central serous chorioretinopathy | |
| Wong et al. | Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry | |
| AU2008320965B2 (en) | Method and apparatus for detecting diseases associated with the eye | |
| Kaya et al. | Comparison of macular pigment in patients with age‐related macular degeneration and healthy control subjects–a study using spectral fundus reflectance | |
| Liu et al. | Analysis of foveal microvascular abnormalities in diabetic retinopathy using optical coherence tomography angiography with projection artifact removal | |
| Gillies et al. | Familial asymptomatic macular telangiectasia type 2 | |
| Schmidt et al. | Fundus autofluorescence lifetimes are increased in non‐proliferative diabetic retinopathy | |
| Kar et al. | Local abundance of macular xanthophyll pigment is associated with rod-and cone-mediated vision in aging and age-related macular degeneration | |
| Henrich et al. | Anatomical and functional outcome in brilliant blue G assisted chromovitrectomy | |
| Hammer et al. | Progressive dysmorphia of retinal pigment epithelium in age-related macular degeneration investigated by fluorescence lifetime imaging | |
| Hammer et al. | Fundus autofluorescence lifetimes and spectral features of soft drusen and hyperpigmentation in age-related macular degeneration | |
| Chan | Recent advances in optic neuritis related to multiple sclerosis | |
| Tran et al. | Rise of intraocular pressure in a caffeine test versus the water drinking test in patients with glaucoma | |
| Hammer et al. | Fundus autofluorescence beyond lipofuscin: lesson learned from ex vivo fluorescence lifetime imaging in porcine eyes | |
| Schultz et al. | Spectral fundus autofluorescence peak emission wavelength in ageing and AMD | |
| Huang et al. | Multispectral image analysis in Vogt–Koyanagi–Harada disease |